We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$10.5B
AUM Growth
-$388M
Cap. Flow
-$87.6M
Cap. Flow %
-0.84%
Top 10 Hldgs %
14.73%
Holding
713
New
186
Increased
183
Reduced
156
Closed
168

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$120M
2
CHRD icon
Chord Energy
CHRD
+$106M
3
EA icon
Electronic Arts
EA
+$96.9M
4
DGX icon
Quest Diagnostics
DGX
+$89.2M
5
ST icon
Sensata Technologies
ST
+$76.1M

Sector Composition

Rank Sector Weight
1 Healthcare 42.43%
2 Technology 19.78%
3 Energy 7.84%
4 Industrials 7.21%
5 Financials 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOW icon
451
ServiceNow
NOW
$120B
$1.16M 0.01%
7,365
-58,670
-89% -$8.61M
AWI icon
452
Armstrong World Industries
AWI
$7.7B
$1.14M 0.01%
10,073
-71,744
-88% -$8.32M
CNTA
453
DELISTED
Centessa Pharmaceuticals
CNTA
$1.11M 0.01%
+123,461
New +$1.17M
PLRX icon
454
Pliant Therapeutics
PLRX
$65.6M
$1.11M 0.01%
103,623
+3,480
+3% +$44.9K
OTLK icon
455
Outlook Therapeutics
OTLK
$175M
$1.11M 0.01%
+150,786
New +$1.21M
CART icon
456
Maplebear
CART
$10.8B
$1.11M 0.01%
+34,602
New +$1.19M
GUTS icon
457
Fractyl Health
GUTS
$111M
$1.11M 0.01%
259,548
+48,585
+23% +$313K
BMEA icon
458
Biomea Fusion
BMEA
$89.7M
$1.06M 0.01%
236,419
-228,154
-49% -$2.32M
BBOT
459
BridgeBio Oncology
BBOT
$683M
$1.06M 0.01%
103,247
-3,458
-3% -$35.6K
GD icon
460
General Dynamics
GD
$105B
$1.03M 0.01%
+3,558
New +$1.04M
POWI icon
461
Power Integrations
POWI
$3.55B
$1M 0.01%
+14,299
New +$1.03M
KYTX icon
462
Kyverna Therapeutics
KYTX
$472M
$997K 0.01%
132,900
-260,028
-66% -$3.97M
AMLX icon
463
Amylyx Pharmaceuticals
AMLX
$2.44B
$995K 0.01%
523,772
TCRX icon
464
TScan Therapeutics
TCRX
$48.1M
$956K 0.01%
+163,492
New +$1.29M
BLUE
465
DELISTED
bluebird bio
BLUE
$954K 0.01%
48,467
-291
-0.6% -$5.83K
G icon
466
Genpact
G
$5.97B
$953K 0.01%
29,604
+9,760
+49% +$315K
INTU icon
467
Intuit
INTU
$87.6B
$932K 0.01%
+1,418
New +$880K
AKAM icon
468
Akamai
AKAM
$17.8B
$921K 0.01%
+10,223
New +$988K
SVCO
469
Silvaco Group
SVCO
$295M
$899K 0.01%
+50,000
New +$910K
VTYX
470
DELISTED
Ventyx Biosciences
VTYX
$876K 0.01%
+379,175
New +$1.58M
ILMN icon
471
Illumina
ILMN
$29.9B
$855K 0.01%
+8,195
New +$919K
AMPL icon
472
Amplitude
AMPL
$1.3B
$842K 0.01%
+94,642
New +$889K
VIGL
473
DELISTED
Vigil Neuroscience
VIGL
$826K 0.01%
+206,614
New +$707K
MSM icon
474
MSC Industrial Direct
MSM
$7.07B
$806K 0.01%
+10,159
New +$902K
AAPL icon
475
Apple
AAPL
$4.51T
$805K 0.01%
3,821
-331,670
-99% -$61.9M

Similar funds

Woodline Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Woodline Partners held 713 positions worth $10.5B, down 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Woodline Partners's Q2 2024 filing shows 186 new, 183 increased, 156 reduced and 168 closed positions. Its largest new stake was Marsh: 585,204 shares worth $123M. The largest sale was Analog Devices, an estimated $138M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Energy.

  • Woodline Partners's largest Q2 2024 buy was Marsh: 585,204 shares worth $123M.
  • Woodline Partners added most to Chord Energy in Q2 2024, an estimated $106M increase.
  • Woodline Partners's biggest Q2 2024 reduction was Avnet, cutting an estimated $130M.
  • Woodline Partners fully exited Analog Devices in Q2 2024, selling an estimated $138M.
  • Woodline Partners's ten largest holdings make up 15% of its $10.5B portfolio in Q2 2024.
  • Woodline Partners opened 186 new positions and closed 168 in Q2 2024.
  • Woodline Partners's portfolio value fell 3.6% quarter-over-quarter to $10.5B.

Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.